Angela Stefanachi

17PUBLICATIONS
60CO-AUTHORS
Biologically active moleculesPharmaceutical delivery technologiesCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 31, 2026
Discovery of a Peripherally Directed CB1 Receptor Antagonist That Restores Insulin Signaling in Adipocytes.

|Oct 27, 2026
N-Adamantyl-1-Pentyl-4-Oxo-1,4-Dihydroquinoline-3-Carboxamide and N-(Adamantan-1-Yl)-2-(Alkyloxy)benzamide Derivatives as Fluorescent Probes for Selective CB2R Targeting.

|Oct 23, 2026
Design and Development of New Dual Target Agents, Cannabinoid Subtype 2 Receptor (CB2R) Agonists, and Fatty Acid Amide Hydrolase (FAAH) Inhibitors against Neurodegeneration.

|Sep 26, 2026
PROTAC-Based Strategies in Neurodegenerative Diseases: Challenges and Perspectives.

|Aug 12, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects.

Claudia Gioé-Gallo, Sandra Ortigueira, Rubén Prieto-Díaz

|Feb 26, 2025
Playing Around the Coumarin Core in the Discovery of Multimodal Compounds Directed at Alzheimer's-Related Targets: A Recent Literature Overview.

Mariagrazia Rullo, Gabriella La Spada, Angela Stefanachi

Pageof 3

Frequent Collaborators

10 joint publications

Marialessandra Contino

9 joint publications

Eddy Sotelo

7 joint publications

Giuseppe Felice Mangiatordi

6 joint publications

Maria Isabel Loza